BioHarvest Sciences Inc.
BHSTConsumer DefensiveNASDAQPackaged Foods
Scan Results
Daily timeframeHeadquartered within the consumer defensive sector, BioHarvest Sciences Inc. focuses on Packaged Foods services and products. BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. With a market capitalization of $39.0M, it sits in micro-cap territory. It operates through two segments: Products and CDMO Services.
Market Cap
$39.0M
Beta
1.38
P/E (TTM)
—
P/E (Fwd)
-5.13
EPS (TTM)
$-0.51
EPS (Fwd)
$-0.34
ROE
-142.5%
ROA
-11.0%
Cash
$16.2M
Total Debt
$15.7M
Free CF
-$11.8M
52W Change
-85.1%
Annual Financials
Cash vs Debt
Where BHST stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, BHST finished 38.78% below its 150-day moving average ($2.94) and 47.06% below its 200-day moving average ($3.40). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is BHST overbought or oversold?
At the October 20, 2026 close, BHST's RSI(14) was 70.6, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $16.2M in cash and $15.7M in debt, BHST maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow is running at -$11.8M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -142.5% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $5.5M (2022) to $34.5M (2025), reflecting a 528% increase over the period.
Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for BioHarvest Sciences Inc. and its sector.